4.5 Article

Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles

Vivian E. Saper et al.

Summary: Drug reaction with eosinophilia and systemic symptoms (DRESS) can occur in Still's disease patients treated with IL-1/IL-6 inhibitors, with features such as eosinophilia, liver enzyme elevation, and persistent rash. HLA-DRB1*15 haplotypes are significantly enriched in Still's disease with DRESS. Pre-prescription HLA typing and vigilance for serious reactions to these drugs are recommended.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Medicine, General & Internal

Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

F. Locatelli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Rheumatology

Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors

Grant S. Schulert et al.

ARTHRITIS & RHEUMATOLOGY (2019)

Review Rheumatology

Macrophage activation syndrome in the era of biologic therapy

Alexei A. Grom et al.

NATURE REVIEWS RHEUMATOLOGY (2016)

Review Immunology

Immunogenetics of juvenile idiopathic arthritis: A comprehensive review

Aimee O. Hersh et al.

JOURNAL OF AUTOIMMUNITY (2015)

Review Rheumatology

Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome

P Woo

NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)